The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Antihypertensive-Global Market Insights and Sales Trends 2024

Antihypertensive-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1858763

No of Pages : 124

Ask Your Query
Synopsis
The global Antihypertensive market size is expected to reach US$ 22370 million by 2029, growing at a CAGR of 2.1% from 2023 to 2029. The market is mainly driven by the significant applications of Antihypertensive in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others, are propelling Antihypertensive market. Diuretics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Angiotensin Converting Enzyme (ACE) Inhibitors segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antihypertensive, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antihypertensive market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antihypertensive market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antihypertensive sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antihypertensive covered in this report include Pfizer, Norvatis, Merck & Co., Sanofi, AstraZeneca, GSK, Daiichi-Sankyo, Boehringer-Ingelheim and Bayer, etc.
The global Antihypertensive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Norvatis
Merck & Co.
Sanofi
AstraZeneca
GSK
Daiichi-Sankyo
Boehringer-Ingelheim
Bayer
Johnson & Johnson
Bristol-Myers Squibb
Tekeda
Ranbaxy Laboratories
Shihuida Pharm
Second Pharmaceutical
Lupin Limited.
Yangtze River Pharmaceutical
Hengrui Medicine
Qilu Pharmaceutical
HUALON
Dawnrays
HISUN Pharmceutical
Global Antihypertensive market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antihypertensive market, Segment by Type:
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators & Renin Inhibitors
Global Antihypertensive market, by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antihypertensive manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antihypertensive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Antihypertensive Market Overview
1.1 Antihypertensive Product Overview
1.2 Antihypertensive Market Segment by Type
1.2.1 Diuretics
1.2.2 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.3 Angiotensin Receptor Blockers (ARBs)
1.2.4 Calcium Channel Blockers
1.2.5 Beta Blockers
1.2.6 Alpha Blockers
1.2.7 Vasodilators & Renin Inhibitors
1.3 Global Antihypertensive Market Size by Type
1.3.1 Global Antihypertensive Market Size Overview by Type (2018-2029)
1.3.2 Global Antihypertensive Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antihypertensive Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antihypertensive Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antihypertensive Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antihypertensive Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antihypertensive Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antihypertensive Sales Breakdown by Type (2018-2023)
2 Global Antihypertensive Market Competition by Company
2.1 Global Top Players by Antihypertensive Sales (2018-2023)
2.2 Global Top Players by Antihypertensive Revenue (2018-2023)
2.3 Global Top Players by Antihypertensive Price (2018-2023)
2.4 Global Top Manufacturers Antihypertensive Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antihypertensive Market Competitive Situation and Trends
2.5.1 Antihypertensive Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antihypertensive Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antihypertensive as of 2022)
2.7 Date of Key Manufacturers Enter into Antihypertensive Market
2.8 Key Manufacturers Antihypertensive Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antihypertensive Status and Outlook by Region
3.1 Global Antihypertensive Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antihypertensive Historic Market Size by Region
3.2.1 Global Antihypertensive Sales in Volume by Region (2018-2023)
3.2.2 Global Antihypertensive Sales in Value by Region (2018-2023)
3.2.3 Global Antihypertensive Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antihypertensive Forecasted Market Size by Region
3.3.1 Global Antihypertensive Sales in Volume by Region (2024-2029)
3.3.2 Global Antihypertensive Sales in Value by Region (2024-2029)
3.3.3 Global Antihypertensive Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antihypertensive by Application
4.1 Antihypertensive Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.1.4 Others
4.2 Global Antihypertensive Market Size by Application
4.2.1 Global Antihypertensive Market Size Overview by Application (2018-2029)
4.2.2 Global Antihypertensive Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antihypertensive Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antihypertensive Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antihypertensive Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antihypertensive Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antihypertensive Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antihypertensive Sales Breakdown by Application (2018-2023)
5 North America Antihypertensive by Country
5.1 North America Antihypertensive Historic Market Size by Country
5.1.1 North America Antihypertensive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antihypertensive Sales in Volume by Country (2018-2023)
5.1.3 North America Antihypertensive Sales in Value by Country (2018-2023)
5.2 North America Antihypertensive Forecasted Market Size by Country
5.2.1 North America Antihypertensive Sales in Volume by Country (2024-2029)
5.2.2 North America Antihypertensive Sales in Value by Country (2024-2029)
6 Europe Antihypertensive by Country
6.1 Europe Antihypertensive Historic Market Size by Country
6.1.1 Europe Antihypertensive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antihypertensive Sales in Volume by Country (2018-2023)
6.1.3 Europe Antihypertensive Sales in Value by Country (2018-2023)
6.2 Europe Antihypertensive Forecasted Market Size by Country
6.2.1 Europe Antihypertensive Sales in Volume by Country (2024-2029)
6.2.2 Europe Antihypertensive Sales in Value by Country (2024-2029)
7 Asia-Pacific Antihypertensive by Region
7.1 Asia-Pacific Antihypertensive Historic Market Size by Region
7.1.1 Asia-Pacific Antihypertensive Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antihypertensive Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antihypertensive Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antihypertensive Forecasted Market Size by Region
7.2.1 Asia-Pacific Antihypertensive Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antihypertensive Sales in Value by Region (2024-2029)
8 Latin America Antihypertensive by Country
8.1 Latin America Antihypertensive Historic Market Size by Country
8.1.1 Latin America Antihypertensive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antihypertensive Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antihypertensive Sales in Value by Country (2018-2023)
8.2 Latin America Antihypertensive Forecasted Market Size by Country
8.2.1 Latin America Antihypertensive Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antihypertensive Sales in Value by Country (2024-2029)
9 Middle East and Africa Antihypertensive by Country
9.1 Middle East and Africa Antihypertensive Historic Market Size by Country
9.1.1 Middle East and Africa Antihypertensive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antihypertensive Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antihypertensive Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antihypertensive Forecasted Market Size by Country
9.2.1 Middle East and Africa Antihypertensive Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antihypertensive Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Antihypertensive Products Offered
10.1.5 Pfizer Recent Development
10.2 Norvatis
10.2.1 Norvatis Company Information
10.2.2 Norvatis Introduction and Business Overview
10.2.3 Norvatis Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Norvatis Antihypertensive Products Offered
10.2.5 Norvatis Recent Development
10.3 Merck & Co.
10.3.1 Merck & Co. Company Information
10.3.2 Merck & Co. Introduction and Business Overview
10.3.3 Merck & Co. Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck & Co. Antihypertensive Products Offered
10.3.5 Merck & Co. Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Antihypertensive Products Offered
10.4.5 Sanofi Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AstraZeneca Antihypertensive Products Offered
10.5.5 AstraZeneca Recent Development
10.6 GSK
10.6.1 GSK Company Information
10.6.2 GSK Introduction and Business Overview
10.6.3 GSK Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GSK Antihypertensive Products Offered
10.6.5 GSK Recent Development
10.7 Daiichi-Sankyo
10.7.1 Daiichi-Sankyo Company Information
10.7.2 Daiichi-Sankyo Introduction and Business Overview
10.7.3 Daiichi-Sankyo Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Daiichi-Sankyo Antihypertensive Products Offered
10.7.5 Daiichi-Sankyo Recent Development
10.8 Boehringer-Ingelheim
10.8.1 Boehringer-Ingelheim Company Information
10.8.2 Boehringer-Ingelheim Introduction and Business Overview
10.8.3 Boehringer-Ingelheim Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Boehringer-Ingelheim Antihypertensive Products Offered
10.8.5 Boehringer-Ingelheim Recent Development
10.9 Bayer
10.9.1 Bayer Company Information
10.9.2 Bayer Introduction and Business Overview
10.9.3 Bayer Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bayer Antihypertensive Products Offered
10.9.5 Bayer Recent Development
10.10 Johnson & Johnson
10.10.1 Johnson & Johnson Company Information
10.10.2 Johnson & Johnson Introduction and Business Overview
10.10.3 Johnson & Johnson Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Johnson & Johnson Antihypertensive Products Offered
10.10.5 Johnson & Johnson Recent Development
10.11 Bristol-Myers Squibb
10.11.1 Bristol-Myers Squibb Company Information
10.11.2 Bristol-Myers Squibb Introduction and Business Overview
10.11.3 Bristol-Myers Squibb Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Bristol-Myers Squibb Antihypertensive Products Offered
10.11.5 Bristol-Myers Squibb Recent Development
10.12 Tekeda
10.12.1 Tekeda Company Information
10.12.2 Tekeda Introduction and Business Overview
10.12.3 Tekeda Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Tekeda Antihypertensive Products Offered
10.12.5 Tekeda Recent Development
10.13 Ranbaxy Laboratories
10.13.1 Ranbaxy Laboratories Company Information
10.13.2 Ranbaxy Laboratories Introduction and Business Overview
10.13.3 Ranbaxy Laboratories Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Ranbaxy Laboratories Antihypertensive Products Offered
10.13.5 Ranbaxy Laboratories Recent Development
10.14 Shihuida Pharm
10.14.1 Shihuida Pharm Company Information
10.14.2 Shihuida Pharm Introduction and Business Overview
10.14.3 Shihuida Pharm Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Shihuida Pharm Antihypertensive Products Offered
10.14.5 Shihuida Pharm Recent Development
10.15 Second Pharmaceutical
10.15.1 Second Pharmaceutical Company Information
10.15.2 Second Pharmaceutical Introduction and Business Overview
10.15.3 Second Pharmaceutical Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Second Pharmaceutical Antihypertensive Products Offered
10.15.5 Second Pharmaceutical Recent Development
10.16 Lupin Limited.
10.16.1 Lupin Limited. Company Information
10.16.2 Lupin Limited. Introduction and Business Overview
10.16.3 Lupin Limited. Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Lupin Limited. Antihypertensive Products Offered
10.16.5 Lupin Limited. Recent Development
10.17 Yangtze River Pharmaceutical
10.17.1 Yangtze River Pharmaceutical Company Information
10.17.2 Yangtze River Pharmaceutical Introduction and Business Overview
10.17.3 Yangtze River Pharmaceutical Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Yangtze River Pharmaceutical Antihypertensive Products Offered
10.17.5 Yangtze River Pharmaceutical Recent Development
10.18 Hengrui Medicine
10.18.1 Hengrui Medicine Company Information
10.18.2 Hengrui Medicine Introduction and Business Overview
10.18.3 Hengrui Medicine Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Hengrui Medicine Antihypertensive Products Offered
10.18.5 Hengrui Medicine Recent Development
10.19 Qilu Pharmaceutical
10.19.1 Qilu Pharmaceutical Company Information
10.19.2 Qilu Pharmaceutical Introduction and Business Overview
10.19.3 Qilu Pharmaceutical Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Qilu Pharmaceutical Antihypertensive Products Offered
10.19.5 Qilu Pharmaceutical Recent Development
10.20 HUALON
10.20.1 HUALON Company Information
10.20.2 HUALON Introduction and Business Overview
10.20.3 HUALON Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.20.4 HUALON Antihypertensive Products Offered
10.20.5 HUALON Recent Development
10.21 Dawnrays
10.21.1 Dawnrays Company Information
10.21.2 Dawnrays Introduction and Business Overview
10.21.3 Dawnrays Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Dawnrays Antihypertensive Products Offered
10.21.5 Dawnrays Recent Development
10.22 HISUN Pharmceutical
10.22.1 HISUN Pharmceutical Company Information
10.22.2 HISUN Pharmceutical Introduction and Business Overview
10.22.3 HISUN Pharmceutical Antihypertensive Sales, Revenue and Gross Margin (2018-2023)
10.22.4 HISUN Pharmceutical Antihypertensive Products Offered
10.22.5 HISUN Pharmceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antihypertensive Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antihypertensive Industrial Chain Analysis
11.4 Antihypertensive Market Dynamics
11.4.1 Antihypertensive Industry Trends
11.4.2 Antihypertensive Market Drivers
11.4.3 Antihypertensive Market Challenges
11.4.4 Antihypertensive Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antihypertensive Distributors
12.3 Antihypertensive Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock